Urgent.News

What's breaking now, across thousands of outlets.

Monday, 26 October 2026 Reading Room

Finance & Markets

Elevra Lithium Completes Sale of Ewoyaa Project Interest

BRISBANE, Australia, Oct. 26, 2026 (GLOBE NEWSWIRE) — North American lithium producer Elevra Lithium Limited (“Elevra” or “Company”) (ASX:ELV; NASDAQ:ELVR) is pleased to announce that it has completed the sale of all of its rights and interests in the Ewoyaa Lithium Project (“Ewoyaa Project”) in Ghana to Zhejiang Huayou Cobalt Co., Ltd. (“Huayou”), as announced on […]

financialpost.com ·

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Finance & Markets

Adobe vs. Docusign: Which Technology Stock Is a Better Buy in 2026?

Adobe trades at a 7.2x forward P/E discount to DocuSign, while DocuSign is pivoting beyond e-signatures to agreement management.

  • Adobe reported $23.8 billion revenue growth, 10.5% YoY increase in 2025
  • Docusign generated $3.2 billion revenue, 8.2% YoY growth in 2026
  • Adobe's P/S ratio decreased to 4.1x, more affordable than Docusign's 5.1x

·fool.com

Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy?

RSPH offers broader healthcare exposure with lower volatility and higher dividend yield, while IBB provides concentrated biotech focus with stronger recent returns.

  • Invesco's RSPH offers diversified, equal-weighted healthcare strategy
  • IBB provides focused, market-cap-weighted exposure to biotechnology
  • RSPH has lower expense ratio (0.4%) and higher yield (0.6%) vs IBB's (0.44%) and 0.2%

·fool.com

More from Monday 26 October →